WeightWatchers CEO Sima Sistani talks TikTok,...

Kara sits down with Bravo network icon Andy Cohen, the host and executive producer of Watch What Happens Live and executive producer of the Real Housewives franchise. He takes Kara on a tour of the business behind the reality TV juggernaut and why he sees himself as less of a “Br ...  Show more

As a longtime partner and former chairman of the legendary Silicon Valley venture capital firm Sequoia, Sir Michael Moritz had a direct hand in building the modern internet. His early investments in companies like PayPal, Google, and YouTube earned him a reputation as a kingmaker ...  Show more

Long before WeightWatchers became a weight loss empire, the legacy dieting company started as a small support group in the 1960s. The company rose to popularity preaching a message of moderation and making healthy choices. But in what some call a surprising pivot, WeightWatchers ...  Show more

WeightWatchers is struggling. Launched in the early 1960s, the brand grew by helping members shed pounds through behavioural change programmes. Then, GLP-1 anti-obesity drugs hit the market, long-time spokesperson and board member Oprah Winfrey announced her departure, and the ...

It’s become a multibillion-dollar business: weight loss drugs. Demand is high, as is the cost. How did medications like Ozempic, Wegovy, Mounjaro and Zepbound become so popular and so profitable? And what kind of impact might they have on the future of food and healthcare? Dr. Sa ...  Show more

Weight-loss drugs have become a golden formula for pharma growth. In this episode we speak to Sector Advisor Maria Latorre and Senior Economist Michaela Grimm about how GLP-1 treatments like Ozempic and Wegovy are reshaping the industry, and the risks that lie ahead. SHOWNOTES: • ...  Show more